Related references
Note: Only part of the references are listed.Impact of SGLT2 Inhibitor Therapy on Right Ventricular Function in Patients with Heart Failure and Reduced Ejection Fraction
Ivona Mustapic et al.
JOURNAL OF CLINICAL MEDICINE (2023)
Echocardiographic evaluation of the effect of dapagliflozin on epicardial adipose tissue and left ventricular systolic function in type 2 diabetes mellitus
Xiang-ting Song et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2023)
The unexpected benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors
Chok G. Chan et al.
NEW ZEALAND MEDICAL JOURNAL (2022)
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
Muthiah Vaduganathan et al.
LANCET (2022)
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
Pardeep S. Jhund et al.
NATURE MEDICINE (2022)
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
S. D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Effect of sodium-glucose cotransporter 2 inhibitors on cardiac structure and function in type 2 diabetes mellitus patients with or without chronic heart failure: a meta-analysis
Yi-Wen Yu et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction
Carlos G. Santos-Gallego et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
Michael E. Nassif et al.
NATURE MEDICINE (2021)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh et al.
EUROPEAN HEART JOURNAL (2021)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D. Anker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks
Rachel J. Perry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Sodium-glucose cotransporter 2 inhibitors' mechanisms of action in heart failure
Petra Grubic Rotkvic et al.
WORLD JOURNAL OF DIABETES (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effects of empagliflozin treatment on cardiac function and structure in patients with type 2 diabetes: a cardiac magnetic resonance study
Neale D. Cohen et al.
INTERNAL MEDICINE JOURNAL (2019)
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease The EMPA-HEART CardioLink-6 Randomized Clinical Trial
Subodh Verma et al.
CIRCULATION (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The effects of sodium-glucose cotransporter 2 inhibitors on left ventricular function: current evidence and future directions
Nick S. R. Lan et al.
ESC HEART FAILURE (2019)
Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes
Daisuke Matsutani et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
Petar M. Seferovic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging
Luigi P. Badano et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2018)
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
Kenneth W. Mahaffey et al.
CIRCULATION (2018)
The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis
Selma Bouthoorn et al.
DIABETES & VASCULAR DISEASE RESEARCH (2018)
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Aidin Rawshani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure
Fumitaka Soga et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Sodium-dependent glucose transporters (SGLT) in human ischemic heart: A new potential pharmacological target
Alessandra Di Franco et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Diagnostic approaches for diabetic cardiomyopathy
A. Lorenzo-Almoros et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial?
Subodh Verma et al.
DIABETES CARE (2016)
Usefulness of speckle myocardial imaging modalities for differential diagnosis of left ventricular non-compaction of the myocardium
Marcelino Cortes et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Sherif F. Nagueh et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2016)
Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I
Ursula Hoffmann et al.
BMC CARDIOVASCULAR DISORDERS (2015)
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry
Matthew A. Cavender et al.
CIRCULATION (2015)
Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)
Wei Song et al.
GENE (2015)
Plasma Cardiotrophin-1 as a Marker of Hypertension and Diabetes-Induced Target Organ Damage and Cardiovascular Risk
Luis Gamella-Pozuelo et al.
MEDICINE (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Roberto M. Lang et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2015)
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi et al.
DIABETES CARE (2015)
Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging
Jens-Uwe Voigt et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2015)
Usefulness of a Combination of Monocyte Chemoattractant Protein-1, Galectin-3, and N-Terminal Probrain Natriuretic Peptide to Predict Cardiovascular Events in Patients With Coronary Artery Disease
Jose Tunon et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion
Evelien E. S. van Riet et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Use of Myocardial Strain Imaging by Echocardiography for the Early Detection of Cardiotoxicity in Patients During and After Cancer Chemotherapy
Paaladinesh Thavendiranathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Risk Prediction in Patients With Heart Failure A Systematic Review and Analysis
Kazem Rahimi et al.
JACC-HEART FAILURE (2014)
Distinguishing focal fibrotic lesions and non-fibrotic lesions in hypertrophic cardiomyopathy by assessment of regional myocardial strain using two-dimensional speckle tracking echocardiography: Comparison with multislice CT
Rei Yajima et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects
Ele Ferrannini et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Impact of aortic stenosis on longitudinal myocardial deformation during exercise
Erwan Donal et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2011)
Subclinical Left Ventricular Dysfunction in Asymptomatic Severe Aortic Regurgitation Patients with Normal Ejection Fraction: A Combined Tissue Doppler and Velocity Vector Imaging Study
Yelda Tayyareci et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2010)
Prognostic Significance of Strain Doppler Imaging in Light-Chain Amyloidosis
Jun Koyama et al.
JACC-CARDIOVASCULAR IMAGING (2010)
Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus: implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography
Jong-Won Ha et al.
HEART (2007)
Clinical epidemiology of heart failure
Arend Mosterd et al.
HEART (2007)
Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes - Importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy
P Poirier et al.
DIABETES CARE (2001)
Share Paper
